Vape controversy is officially starting to hurt the weed industry’s bottom line
Cannabis vape sales have dropped 15 per cent in the U.S. since reports of vaping-related illnesses began hitting the headlines
By Kieran Delamont
Depending on who you ask, the recent illnesses related to vaping in the U.S. are either a dire health warning or a bit of a moral panic.
But whichever side you come down on, one thing is for sure – weed companies are starting to feel the heat.
Legal weed’s role in the illnesses reported so far isn’t all that clear. Some have been linked to THC vape pens. But it’s a lot harder to trace whether those involve legal cartridges, legal juice, and so on. According to The Guardian, cannabis vape sales have dropped significantly in the U.S. since the vape illnesses began hitting the headlines, 15 per cent alone in the first week of September.
Alex Halperin, weed columnist for The Guardian, is calling this legal weed’s “first crisis.” And it may well be. That’s partly because most consumers can’t tell the difference between THC vapes, nicotine vapes, or their legal and illegal counterparts.
So far, more than 800 people have been affected in the U.S., and 13 people have died.